Skip to content
zameds

Temozolomide

Sold as Temodal, Accord-temozolomide, Temintas

S4
Loading the molecular structure
C6H6N6O2194.15 g/mol

3-Methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide

Drag to rotate. Structure from PubChem CID 5394.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
3
Registrations
13
Schedule source
Consolidated Schedules 06 July 2026

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Msd (Pty) LtdTemodal20 mg, 100 mg, 140 mg, 180 mg, 250 mg320722, 320723, 320724, 420961, 420962S4None
Accord Healthcare (Pty) LtdAccord-temozolomide5, 20, 100, 250440960, 440961, 440962, 440963S4None
Eurolab (Pty) LtdCertificate held by Eurolab (Pty) Ltd.Temintas5 mg/20 mg/100 mg/ 250mg440964, 440965, 440966, 440967S4PIPIL

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Temodal 20 MG capsules

EACH CAPSULE CONTAINS TEMOZOLOMIDE 20,0 mg

20 mgCapsules32072232/26/0722RegisteredS4None
Temodal 100 MG capsules

EACH CAPSULE CONTAINS TEMOZOLOMIDE 100,0 mg

100 mgCapsules32072332/26/0723RegisteredS4None
Temodal 250 MG capsules

EACH CAPSULE CONTAINS TEMOZOLOMIDE 250,0 mg

250 mgCapsules32072432/26/0724RegisteredS4None
Temodal 140 MG capsules

EACH CAPSULE CONTAINS TEMOZOLOMIDE 140,0 mg

140 mgCapsules42096142/26/0961RegisteredS4None
Temodal 180 MG capsules

EACH CAPSULE CONTAINS TEMOZOLOMIDE 180,0 mg

180 mgCapsules42096242/26/0962RegisteredS4None
Accord-temozolomide 5

EACH CAPSULE CONTAINS TEMOZOLOMIDE 5,0 mg

544096044/26/0960RegisteredS4None
Accord-temozolomide 20

EACH CAPSULE CONTAINS TEMOZOLOMIDE 20,0 mg

2044096144/26/0961RegisteredS4None
Accord-temozolomide 100

EACH CAPSULE CONTAINS TEMOZOLOMIDE 100,0 mg

10044096244/26/0962RegisteredS4None
Accord-temozolomide 250

EACH CAPSULE CONTAINS TEMOZOLOMIDE 250,0 mg

25044096344/26/0963RegisteredS4None
Temintas 5

EACH CAPSULE CONTAINS TEMOZOLOMIDE 5,0 mg

5 mg/20 mg/100 mg/ 250mgHard gelatin capsules44096444/26/0964Approved 8 October 2024RegisteredS4PIPIL
Temintas 20

EACH CAPSULE CONTAINS TEMOZOLOMIDE 20,0 mg

5 mg/20 mg/100 mg/ 250mgHard gelatin capsules44096544/26/0965Approved 8 October 2024RegisteredS4PIPIL
Temintas 100

EACH CAPSULE CONTAINS TEMOZOLOMIDE 100,0 mg

5 mg/20 mg/100 mg/ 250mgHard gelatin capsules44096644/26/0966Approved 8 October 2024RegisteredS4PIPIL
Temintas 250

EACH CAPSULE CONTAINS TEMOZOLOMIDE 250,0 mg

5 mg/20 mg/100 mg/ 250mgHard gelatin capsules44096744/26/0967Approved 8 October 2024RegisteredS4PIPIL

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Temozolomide

  • S4: Temozolomide

    Consolidated Schedules 06 July 2026, line 8122

Pharmacological class: Cytostatic agents (class 26)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsTemintas 5, Eurolab (Pty) LtdPatient information leaflet (PIL)For patients and carersTemintas 5, Eurolab (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles